Regadenoson clinical trials
Also written Lexiscan and CVT3146.
How each study uses regadenoson is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the regadenoson studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 10 Apr 2008 · LEXISCAN · NDA 022161 (FDA, Drugs@FDA)
- European Union
- 6 Sept 2010 · Rapiscan · EMEA/H/C/001176 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
48 studies that test it; most in 2009 (11)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 11 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 38
University of Maryland, Baltimore (3) · Astellas Pharma Inc (3) · University of Chicago (3) · University of Utah (3) · Gilead Sciences (3) · Emory University (2) · University of Nebraska (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)
Often tested with
Tested in the same studies.
Adenosine (5) · Water O-15 (2) · FS 069 (1) · Gadofosveset trisodium (1) · Temozolomide (1) · Exercise Pain Management (1) · Dobutamine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test regadenoson.
- Dec 2026A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric PatientsPhase 1/2 · GE Healthcare
- Jan 2027Allograft Dysfunction in Heart TransplantPhase 4 · Paul Kim
- Mar 2027New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)Early Phase 1 · University of Utah
Studies
Open first, then newest update. How each study uses regadenoson is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 48
- New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)RecruitingEarly Phase 1University of UtahNCT04600115Written as Regadenoson
- A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric PatientsRecruitingPhase 1/2GE HealthcareNCT04604782Written as Regadenoson
- Allograft Dysfunction in Heart TransplantRecruitingPhase 4Paul KimNCT03102125Written as Regadenoson
- The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPICompletedNot applicableEmory UniversityNCT04316676Written as Regadenoson
- Treat COVID-19 Patients With RegadenosonCompletedPhase 1/2University of Maryland, BaltimoreNCT04606069Written as Regadenoson
- Regadenoson R-T Perfusion Imaging TrialCompletedPhase 1University of NebraskaNCT00837369Written as Regadenoson
- A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)CompletedPhase 2Astellas Pharma IncNCT01334918Written as regadenoson
- Regadenoson Real Time Perfusion Imaging Trial-OptisonCompletedPhase 3University of NebraskaNCT01489176Written as Regadenoson; Optison
- Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle TrackingCompletedPhase 4M.D. Anderson Cancer CenterNCT02130453Written as Regadenoson
- Regadenoson Infusion of Marginalized Donor Lungs in an EVLP SystemCompletedEarly Phase 1University of Maryland, BaltimoreNCT04521569Written as Regadenoson
- Microvascular Blood Flow in Sickle Cell AnemiaCompletedNot applicableVersitiNCT01566890Written as regadenoson infusion with contrast-enhanced ultrasound
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT03971734Written as Regadenoson 0.05mg
- Heart Rate Response to Regadenoson and Sudden Cardiac DeathCompletedNot applicableUniversity of Alabama at BirminghamNCT01842035Written as regadenoson
- Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress TestingCompletedNot applicableUniversity of Maryland, BaltimoreNCT01026012Written as regadenoson
- Stress Testing and Cardiac Magnetic ResonanceCompletedPhase 4University of ChicagoNCT00871260Written as regadenoson
- Stress CT Perfusion in Patients With Chest PainCompletedNot applicableUniversity of ChicagoNCT01969916Written as Regadenoson
- Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEFCompletedPhase 4Marvin W. Kronenberg, M.D.NCT02589977Written as regadenoson
- Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionTerminatedNot applicableNational Jewish HealthNCT02220634Written as Regadenoson
- Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow ReserveTerminatedPhase 4Duke UniversityNCT03249272Written as Regadenoson
- Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion ImagingWithdrawnNot applicableUniversity of UtahNCT02608944Written as Regadenoson
See all 48 studies that test regadenoson →
Given beside what is tested · 6 — regadenoson is usual care or a partner of the new treatment
- Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PETRecruitingPhase 2St. Jude Children's Research HospitalNCT05583721Written as Lexiscan
- Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)CompletedPhase 3Astellas Pharma IncNCT00826280Written as regadenoson
- A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCITerminatedPhase 2SanofiNCT03236311Written as Regadenoson
- Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal VolunteersCompletedPhase 1University of MichiganNCT01433705Written as Regadenoson
- Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion StudiesCompletedNot applicableDaniel S. BermanNCT01949844Written as regadenoson
- The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in VivoStatus unknownPhase 2University of AarhusNCT03090087Written as Regadenoson
Codes
What other systems call regadenoson · ClinicalTrials.gg INT004359
- MeSH (NLM) C430916regadenosonConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2XLN4Y044HREGADENOSONConfirmed FDA, NLM, Wikidata
- RxNorm 640062One source FDA
- Wikidata Q83118320Regadenoson hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74420RegadenosonOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C430916 | regadenoson | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2XLN4Y044H | REGADENOSON | Confirmed FDA, NLM, Wikidata |
| RxNorm | 640062 | — | One source FDA |
| Wikidata | Q83118320 | Regadenoson hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74420 | Regadenoson | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.